Clinical Trials Logo

Clinical Trial Summary

To study the efficacy and safety of amniotic membrane transplantation as an adjunctive therapy after surgical excision of primary pterygium and compare the clinical outcomes with conjunctival autograft


Clinical Trial Description

Prospective Randomized Blind Clinical Trial

Sixty-four eyes of 64 patients with primary nasal pterygium have been operated by two surgeons (E. G-H, A. N-C). All patients are randomized to undergo Mini-SLET or limbal-conjunctival autograft transplantation as an adjuvant therapy after pterygium excision.

Four eyes were treated with Mini-SLET(group 1), and 26 eyes have been operated with conjunctival autograft (group 2). Patients will be followed up at 1 day, 1 week, 1, 3, 6, 9 and 12 months postoperation. The main outcome measurement was a recurrence rate after surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03363282
Study type Interventional
Source Instituto de Oftalmología Fundación Conde de Valenciana
Contact
Status Completed
Phase N/A
Start date September 17, 2015
Completion date November 28, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT03321201 - Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery N/A
Withdrawn NCT03037736 - Outpatient Performed Pterygium Surgery Study Phase 4
Completed NCT03507283 - Vertical Split Conjunctival Autograft in Double-head Pterygia